(19)
(11) EP 2 948 776 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
26.02.2020 Bulletin 2020/09

(45) Mention of the grant of the patent:
04.12.2019 Bulletin 2019/49

(21) Application number: 14743533.3

(22) Date of filing: 24.01.2014
(51) International Patent Classification (IPC): 
G01N 33/574(2006.01)
C12Q 1/68(2018.01)
(86) International application number:
PCT/US2014/013048
(87) International publication number:
WO 2014/117021 (31.07.2014 Gazette 2014/31)

(54)

METHODS, COMPOSITIONS, KITS, AND SYSTEMS FOR SELECTIVE ENRICHMENT OF TARGET CELLS

VERFAHREN, ZUSAMMENSETZUNGEN, KITS UND SYSTEME ZUR SELEKTIVEN ANREICHERUNG VON ZIELZELLEN

PROCÉDÉS, COMPOSITIONS, TROUSSES ET SYSTÈMES POUR L'ENRICHISSEMENT SÉLECTIF DE CELLULES CIBLES


(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(30) Priority: 25.01.2013 US 201361756993 P
04.02.2013 US 201361760626 P

(43) Date of publication of application:
02.12.2015 Bulletin 2015/49

(73) Proprietor: Xcell Biosciences, Inc.
San Francisco, CA 94158 (US)

(72) Inventor:
  • LIM, James
    Oakland, CA 94608 (US)

(74) Representative: Boult Wade Tennant LLP 
Salisbury Square House 8 Salisbury Square
London EC4Y 8AP
London EC4Y 8AP (GB)


(56) References cited: : 
WO-A1-2010/056328
US-A1- 2006 275 836
US-A1- 2010 184 219
US-A1- 2011 020 930
US-A1- 2001 034 061
US-A1- 2008 176 276
US-A1- 2010 216 168
US-A1- 2012 280 686
   
  • LOUIE ELIZABETH ET AL: "Identification of a stem-like cell population by exposing metastatic breast cancer cell lines to repetitive cycles of hypoxia and reoxygenation", BREAST CANCER RESEARCH, CURRENT MEDICINE GROUP LTD, GB, vol. 12, no. 6, 10 November 2010 (2010-11-10), page R94, XP021085404, ISSN: 1465-5411, DOI: 10.1186/BCR2773
  • M. YU ET AL: "Circulating tumor cells: approaches to isolation and characterization", THE JOURNAL OF CELL BIOLOGY, vol. 192, no. 3, 7 February 2011 (2011-02-07), pages 373-382, XP055020222, ISSN: 0021-9525, DOI: 10.1083/jcb.201010021
  • Roberto Scatena ET AL: "Circulating tumour cells and cancer stem cells: A role for proteomics in defining the interrelationships between function, phenotype and differentiation with potential clinical applications", BBA - REVIEWS ON CANCER., vol. 1835, no. 2, 1 April 2013 (2013-04-01), pages 129-143, XP55481688, NL ISSN: 0304-419X, DOI: 10.1016/j.bbcan.2012.12.002
   
Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).